Repligen (RGEN)
(Delayed Data from NSDQ)
$165.66 USD
-2.20 (-1.31%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $165.78 +0.12 (0.07%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Price, Consensus and EPS Surprise
RGEN 165.66 -2.20(-1.31%)
Will RGEN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for RGEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RGEN
PBYI vs. RGEN: Which Stock Is the Better Value Option?
Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y
RGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Repligen (RGEN) Lags Q4 Earnings and Revenue Estimates
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?
Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?
Other News for RGEN
Danaher Q1: The Worst Time Has Already Passed
Artisan Mid Cap Fund Q1 2024 Commentary
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Baron Health Care Fund Q1 2024 Shareholder Letter
Danaher gains as Q1 results exceed expectations